Skip to content
Peptigraph home

GLOW blend calculator

A three-peptide blend vial: GHK-Cu, BPC-157 and TB-500. Work out how much of each peptide is in one draw, from the dose of one peptide or from the units you draw.

Also calledGLOW50GLOW70
Medically reviewed by Juan Pablo Frías, MD · · DisclosureUpdated Educational use only
1Vial and what is in it
mg of each peptide. Change them to match your vial label.
mg
mg
mg
2Bacteriostatic water added
mL
3What you know
Calculate from
Peptide to dose by
Dose of BPC-157
mcg
4Syringe (U-100)
Draw to
5units
= 0.05 mL on a 1 mL U-100 insulin syringe
Each draw contains
  • GHK-Cu1.25 mg71.4%
  • BPC-157250 mcg14.3%
  • TB-500250 mcg14.3%
Vial total
70 mg
Total mg/mL
35
Draws per vial
40
Math only. It does not recommend a dose. Each peptide's share of the draw is fixed by the vial, so you cannot dose one without the others.

GLOW: 5 units (0.05 mL) from a 70 mg vial + 2 mL water = 1.25 mg GHK-Cu, 250 mcg BPC-157, 250 mcg TB-500.

How the blend math works

Each peptide has its own concentration: its milligrams divided by the water you add. Whatever volume you draw, every peptide comes along in proportion. Dosing by one peptide sets the volume, and that volume sets the dose of all the others.

GHK-Cu: 50 mg ÷ 2 mL = 25 mg/mLBPC-157: 10 mg ÷ 2 mL = 5 mg/mLTB-500: 10 mg ÷ 2 mL = 5 mg/mL0.25 mg BPC-157 ÷ 5 mg/mL = 0.05 mL = 5 unitsGHK-Cu: 0.05 mL × 25 mg/mL = 1.25 mgBPC-157: 0.05 mL × 5 mg/mL = 250 mcgTB-500: 0.05 mL × 5 mg/mL = 250 mcg
5 units · 1.25 mg GHK-Cu · 250 mcg BPC-157 · 250 mcg TB-500

What is in a GLOW vial

Amount of each peptide per GLOW vial
Peptide70 mg vial50 mg vial
GHK-Cu50 mg (71.4%)35 mg (70%)
BPC-15710 mg (14.3%)5 mg (10%)
TB-50010 mg (14.3%)10 mg (20%)
These are the typical amounts users report for GLOW vials in community discussions (Jan 2025 to Oct 2026), not a verified label. Sellers fill vials differently, so enter the amounts printed on your vial in the calculator.

What the three ingredients have each been tested for

In a randomised trial of GHK-Cu skin products applied after CO2 laser resurfacing, a questionnaire favoured GHK-Cu for overall skin quality (P = .04).[3]

The same trial concluded that objective evaluation found no significant improvement in wrinkles or overall skin quality.[3]

BPC-157's human evidence is a retrospective review of knee injections, in which 14 of 16 patients contacted reported relief.[4]

The TB-500 healing study cited here is a rat Achilles tendon experiment that its authors describe as exploratory.[5]

Has the trio, or any pair of it, been tested together?

BPC-157 with GHK-Cu: 7 PubMed title/abstract records on 2 Oct 2026, 0 classed as a study of the pair.

Calculated from pubmed query ("BPC-157"[tiab] OR BPC157[tiab] OR "body protection compound"[tiab] OR "pentadecapeptide BPC"[tiab]) AND ("GHK-Cu"[tiab] OR GHK[tiab] OR "copper tripeptide"[tiab] OR "copper peptide"[tiab] OR "copper peptides"[tiab] OR "glycyl-L-histidyl-L-lysine"[tiab] OR "glycyl-histidyl-lysine"[tiab] OR "Gly-His-Lys"[tiab]); search date 2026-10-02; records returned 7; records classed as study of the pair 0. Formula: Counts copied from the combinations dataset (key bpc-157__ghk-cu); no arithmetic applied.

BPC-157 with TB-500: 13 records, of which 1 is classed as a study of the pair (the rat tendon study, which found no added benefit from combining).

Calculated from pubmed query ("BPC-157"[tiab] OR BPC157[tiab] OR "body protection compound"[tiab] OR "pentadecapeptide BPC"[tiab]) AND ("TB-500"[tiab] OR TB500[tiab] OR "thymosin beta-4"[tiab] OR "thymosin beta4"[tiab] OR Tbeta4[tiab]); search date 2026-10-02; records returned 13; records classed as study of the pair 1. Formula: Counts copied from the combinations dataset (key bpc-157__tb-500); no arithmetic applied.

How the community-reported vial amounts split

A 70 mg vial reported as 50 + 10 + 10 mg is 71.4% GHK-Cu, 14.3% BPC-157 and 14.3% TB-500 by weight; a 50 mg vial reported as 35 + 5 + 10 mg is 70%, 10% and 20%.

Calculated from variants mg 70 mg vial (ghk-cu 50, BPC-157 10, TB-500 10), 50 mg vial (ghk-cu 35, BPC-157 5, TB-500 10); basis community-reported (blends dataset). Formula: 50/70 = 71.4%; 10/70 = 14.3%; 35/50 = 70%; 5/50 = 10%; 10/50 = 20%

So in either vial, the copper peptide is about 70% of the powder, and the two injury peptides together are about 29% or 30%.

Calculated from 70 mg vial (10 + 10) / 70 = 28.6%; 50 mg vial (5 + 10) / 50 = 30%. Formula: (BPC-157 + TB-500) / vial total

FDA and WADA wording

FDA's safety-risk page, in its row for injectable GHK-Cu, says there are limited data in humans to inform safety.[6]

Common questions

How many units of GLOW for 250 mcg of BPC-157?

In a 70 mg GLOW vial (50 mg GHK-Cu, 10 mg BPC-157, 10 mg TB-500) mixed with 2 mL of water, BPC-157 is at 5 mg/mL, so 250 mcg is 5 units (0.05 mL) on a U-100 syringe. That same draw also contains 1.25 mg GHK-Cu, 250 mcg TB-500.

How much of each peptide is in 10 units of GLOW?

10 units on a U-100 syringe is 0.10 mL. From a 70 mg GLOW vial (50 mg GHK-Cu, 10 mg BPC-157, 10 mg TB-500) with 2 mL of water, that draw holds 2.5 mg GHK-Cu, 500 mcg BPC-157, 500 mcg TB-500.

What is in the Glow peptide blend?

Community-reported vials combine GHK-Cu, BPC-157 and TB-500; this site's composition data are community-reported, not a manufacturer specification.

Calculated from components GHK-Cu, BPC-157, TB-500; composition basis community-reported. Formula: Components copied from the blends dataset; no arithmetic applied.

Does Glow work for skin?

No study tested the blend. GHK-Cu's randomised skin work is topical, and its objective measures showed no significant improvement in the laser study.[3]

Has anyone tested GHK-Cu with BPC-157?

The dataset search found 7 records mentioning both and none classed as a study of the pair.

Calculated from records returned 7; records classed as study of the pair 0. Formula: Counts copied from the combinations dataset (key bpc-157__ghk-cu); no arithmetic applied.

Sources

  1. 1Metric (SI) Prefixes (NIST Reference on Constants, Units, and Uncertainty)National Institute of Standards and Technology (NIST) · 2025physics.nist.govAccessed 2 Oct 2026
  2. 2BASAGLAR (insulin glargine) injection, prescribing information (DailyMed)U.S. Food and Drug Administration / DailyMed (Eli Lilly and Company label) · 2026dailymed.nlm.nih.govAccessed 2 Oct 2026
  3. 3Effects of topical copper tripeptide complex on CO2 laser-resurfaced skin.Archives of facial plastic surgery · 2006PMID 16847171Accessed 2 Oct 2026
  4. 4Intra-Articular Injection of BPC 157 for Multiple Types of Knee Pain.Alternative therapies in health and medicine · 2021PMID 34324435Accessed 2 Oct 2026
  5. 5Effects of BPC-157 and TB-500 on Achilles tendon healing in rats: A histopathological and biomechanical study.Joint diseases and related surgery · 2026PMID 42542926Accessed 2 Oct 2026
  6. 6Official web pageOfficial web page · web page

Found an error? Report a correction.